Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Long hold for good hedge against inflation, imo
lol pathetic
That's a sure sign of wash trading... they want to sell to themselves, not you. They want to make it appear that people are dumping, but they don't want to lose any money or shares doing it. All imo, of course.
Small dumps didn't work, so they're restoring to wash trading, which is illegal.
No worries... licensing deal is very close!
Don't fall for the manipulation - they're trying to get people to dump!
The patent is gonna be big news, imo!
$CNNA looks ready.
You won't have to just imagine it once news drops.
Low volume but almost all buys today.
How about that 50 share paintdown lol
I think we're at bottom now... loaded 9's and 10's
I don't see any dumping... news coming!
$CTYX here are some comparisons to other orphan drug companies:
"Amgen and Biogen are expected to turn to M&As in the near future as a means to maintain their presence in the orphan drugs sector”
~ Maura Musciacco, GlobalData
Amgen: AMGN (NASDAQ) $258.46
Biogen: BIIB (NASDAQ) $281.88
$CTYX is just getting started, but check out this comparison to see where it might be heading:
Connectyx Technologies Holdings Group, Inc.
$CTYX (OTC) $0.009
OS 322,800,327
Float only 188,707,258
Alexion Pharmaceuticals, Inc.
$ALXN (NASDAQ) $109.24
OS 220,827,431
$CTYX here is a more down-to-earth comparison:
Connectyx Technologies Holdings Group, Inc.
$CTYX (OTC) $0.009
Market Cap $2,905,203
Akcea Therapeutics, Inc.
$AKCA (NASDAQ) $12.87
Market Cap $1,306,423,700
$CTYX and just so you know, Akcea Therapeutics only has 2 approved drugs with six more in the pipeline, while Connectyx Technologies Holdings Group is working on their first. This is the ground floor, but watch how quickly they grow!
$CTYX here are some comparisons to other orphan drug companies:
"Amgen and Biogen are expected to turn to M&As in the near future as a means to maintain their presence in the orphan drugs sector”
~ Maura Musciacco, GlobalData
Amgen: AMGN (NASDAQ) $258.46
Biogen: BIIB (NASDAQ) $281.88
$CTYX is just getting started, but check out this comparison to see where it might be heading:
Connectyx Technologies Holdings Group, Inc.
$CTYX (OTC) $0.009
OS 322,800,327
Float only 188,707,258
Alexion Pharmaceuticals, Inc.
$ALXN (NASDAQ) $109.24
OS 220,827,431
$CTYX here is a more down-to-earth comparison:
Connectyx Technologies Holdings Group, Inc.
$CTYX (OTC) $0.009
Market Cap $2,905,203
Akcea Therapeutics, Inc.
$AKCA (NASDAQ) $12.87
Market Cap $1,306,423,700
$CTYX and just so you know, Akcea Therapeutics only has 2 approved drugs with six more in the pipeline, while Connectyx Technologies Holdings Group is working on their first. This is the ground floor, but watch how quickly they grow!
$CTYX here are some comparisons to other orphan drug companies:
"Amgen and Biogen are expected to turn to M&As in the near future as a means to maintain their presence in the orphan drugs sector”
~ Maura Musciacco, GlobalData
Amgen: AMGN (NASDAQ) $258.46
Biogen: BIIB (NASDAQ) $281.88
$CTYX is just getting started, but check out this comparison to see where it might be heading:
Connectyx Technologies Holdings Group, Inc.
$CTYX (OTC) $0.009
OS 322,800,327
Float only 188,707,258
Alexion Pharmaceuticals, Inc.
$ALXN (NASDAQ) $109.24
OS 220,827,431
$CTYX here is a more down-to-earth comparison:
Connectyx Technologies Holdings Group, Inc.
$CTYX (OTC) $0.009
Market Cap $2,905,203
Akcea Therapeutics, Inc.
$AKCA (NASDAQ) $12.87
Market Cap $1,306,423,700
$CTYX and just so you know, Akcea Therapeutics only has 2 approved drugs with six more in the pipeline, while Connectyx Technologies Holdings Group is working on their first. This is the ground floor, but watch how quickly they grow!
$CTYX here are some comparisons to other orphan drug companies:
"Amgen and Biogen are expected to turn to M&As in the near future as a means to maintain their presence in the orphan drugs sector”
~ Maura Musciacco, GlobalData
Amgen: AMGN (NASDAQ) $258.46
Biogen: BIIB (NASDAQ) $281.88
$CTYX is just getting started, but check out this comparison to see where it might be heading:
Connectyx Technologies Holdings Group, Inc.
$CTYX (OTC) $0.009
OS 322,800,327
Float only 188,707,258
Alexion Pharmaceuticals, Inc.
$ALXN (NASDAQ) $109.24
OS 220,827,431
$CTYX here is a more down-to-earth comparison:
Connectyx Technologies Holdings Group, Inc.
$CTYX (OTC) $0.009
Market Cap $2,905,203
Akcea Therapeutics, Inc.
$AKCA (NASDAQ) $12.87
Market Cap $1,306,423,700
$CTYX and just so you know, Akcea Therapeutics only has 2 approved drugs with six more in the pipeline, while Connectyx Technologies Holdings Group is working on their first. This is the ground floor, but watch how quickly they grow!
$CNNA Advisory Board member Jeremy Amsden is the same guy who turned $MEDH around.
https://www.accesswire.com/595197/Cann-American-Corp-Announces-Advisory-Board
Gettin' my DD together this weekend... holy shit!
Everything under a penny getting loaded.
Mostly buys today - people loading!
Once they start inking deals it's game on!
Oklahoma has about the most liberal mmj laws in the US and you can get your card online. Big business there!
I grabbed a nice chunk of these 9's
The website is cached in your browser. Like I said, clear your browser cache and click on the link again.
Bigger news is coming regarding the delivery service.
Clear your internet cache. Website is not working.
Yup, if I had the whip I would clean all those clowns off the ask right back up to .002
Unfortunately, I do not have that kind of money.
Jason running a tight ship to be sure. No convertible debt. Nice SS. And it looks like he is making some excellent acquisitions. News coming soon!
They know what's coming and trying to load!
5-year prediction: $CTYX trading on NASDAQ over $8.00
Not yet.
OTC Markets is having trouble with their system.
Only went up about 16% compared to the value added by this acquisition... that's really good!
$GTEH SS update 7/10/20
OS 2,708,058,634
Not bad considering they acquired Sinfit in a mostly cash deal!
Great post! Deserves a sticky!
And it'll be silver dollar city shortly thereafter!
Sinfit products at Giant Eagle:
https://shop.gianteagle.com/reagan-parkway-getgo/search?q=Sinfit
"Due to high demand, there may be limited inventory on some items."
Good to have you on board!
Buy the dip, imo. Once this drug deal is finalized, we will have a legit pharmaceutical company and I expect the pps to make a strong move upwards.